✦ LIBER ✦

Dopamine Resistance of Prolactinomas

✍ Scribed by Mark E. Molitch

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Temozolomide in the management of dopami

✍ B. C. Whitelaw; D. Dworakowska; N. W. Thomas; S. Barazi; P. Riordan-Eva; A. P. K 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

Resistant prolactinomas

✍ Vasilev, V.; Daly, A. F.; Vroonen, L.; Zacharieva, S.; Beckers, A. 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 95 KB

Temozolomide in the treatment of an inva

✍ Lisa M. Neff; Michelle Weil; Alan Cole; Thomas R. Hedges; William Shucart; Donal 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 253 KB

Surgical Outcomes in Hyporesponsive Prol

✍ D. Kojo Hamilton; Mary Lee Vance; Paul T. Boulos; Edward R. Laws 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 810 KB

Low levels ofPRB3mRNA are associated wit

✍ Wang, Fei; Gao, Hua; Li, Chuzhong; Bai, Jiwei; Lu, Runchun; Cao, Lei; Wu, Yongtu 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 263 KB

‘Prolactinoma: are dopamine agonists sti

✍ R. G. Beran 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB